About Imugene Limited (IMU)
Imugene Limited is a Biotechnology company operating in the Healthcare sector.
IMU trades on the Australian Securities Exchange and is classified as a large-cap stock .
Key Statistics
- Current Price
- A$0.04
- Market Cap
- A$19.39M
- 52-Week High
- A$0.41
- 52-Week Low
- A$0.03
- Sector
- Healthcare
- Industry
- Biotechnology
A$1,000 Invested in Imugene Limited (IMU)
How much would A$1,000 invested in IMU be worth today?
What would A$1,000 invested in IMU 1 year ago be worth today?
A A$1,000 investment in Imugene Limited (IMU) in 2025 would be worth A$96 as of November 2026, representing a -90.4% total return.
What would A$1,000 invested in IMU 3 years ago be worth today?
A A$1,000 investment in Imugene Limited (IMU) in 2023 would be worth A$24 as of November 2026, representing a -97.6% total return.
What would A$1,000 invested in IMU 5 years ago be worth today?
A A$1,000 investment in Imugene Limited (IMU) in 2021 would be worth A$2 as of November 2026, representing a -99.8% total return.
What would A$1,000 invested in IMU 10 years ago be worth today?
A A$1,000 investment in Imugene Limited (IMU) in 2016 would be worth A$115 as of November 2026, representing a -88.5% total return.
What would A$1,000 invested in IMU at IPO be worth today?
A A$1,000 investment in Imugene Limited (IMU) at IPO would be worth A$1 as of November 2026, representing a -99.9% total return.
Monthly Returns Heatmap
Over the past 32+ years (394 months), Imugene Limited (IMU) has averaged a monthly return of +1.68% with a median return of -2.54%. The stock had 142 positive months (36%) and 207 negative months (53%). The best month in IMU's history was January 2002 with a +400.0% return, while the worst was February 2002 at -81.4%. Historically, July tends to be the strongest month (averaging +14.7%), and June the weakest (-7.9%).
IMU's longest winning streak was 7 consecutive months of gains, while its longest losing streak was 7 consecutive months of losses. The best full year was 2002 with a cumulative return of +379.3%, and the worst was 2001 at -119.1%.
Annual Returns
Over 33 years of trading history, Imugene Limited (IMU) has delivered an average annual return of +6.72% with a median return of -19.79%. The compound annual growth rate (CAGR) is -18.22%. The stock posted gains in 14 years (42%) and losses in 19 years (58%).
IMU's best year was 2021 with a +300.00% gain, while the worst was 2026 at -90.41%. The longest streak of consecutive positive years was 4, and the longest losing streak was 5 years. IMU achieved double-digit gains (10%+) in 12 years. It suffered double-digit losses in 18 years.
| Year | Return | Start | End |
|---|---|---|---|
| 2026 | -90.41% | A$0.37 | A$0.04 |
| 2025 | -70.99% | A$1.26 | A$0.37 |
| 2024 | -66.36% | A$3.74 | A$1.26 |
| 2023 | -24.14% | A$4.93 | A$3.74 |
| 2022 | -63.75% | A$13.60 | A$4.93 |
| 2021 | +300.00% | A$3.40 | A$13.60 |
| 2020 | +212.50% | A$1.09 | A$3.40 |
| 2019 | +77.78% | A$0.61 | A$1.09 |
| 2018 | +20.79% | A$0.51 | A$0.61 |
| 2017 | -20.86% | A$0.64 | A$0.51 |
| 2016 | +58.33% | A$0.40 | A$0.64 |
| 2015 | +20.00% | A$0.34 | A$0.40 |
| 2014 | -41.18% | A$0.57 | A$0.34 |
| 2013 | +54.55% | A$0.37 | A$0.57 |
| 2012 | -8.33% | A$0.40 | A$0.37 |
| 2011 | -78.18% | A$1.85 | A$0.40 |
| 2010 | -37.50% | A$2.97 | A$1.85 |
| 2009 | +3.53% | A$2.86 | A$2.97 |
| 2008 | -43.33% | A$5.05 | A$2.86 |
| 2007 | -40.99% | A$8.57 | A$5.05 |
| 2006 | +37.84% | A$6.21 | A$8.57 |
| 2005 | -30.19% | A$8.90 | A$6.21 |
| 2004 | +3.92% | A$8.57 | A$8.90 |
| 2003 | +64.52% | A$5.21 | A$8.57 |
| 2002 | +47.62% | A$3.53 | A$5.21 |
| 2001 | -77.05% | A$15.37 | A$3.53 |
| 2000 | -49.27% | A$30.30 | A$15.37 |
| 1999 | +110.49% | A$14.39 | A$30.30 |
| 1998 | -19.79% | A$17.94 | A$14.39 |
| 1997 | +50.00% | A$11.96 | A$17.94 |
| 1996 | -25.38% | A$16.03 | A$11.96 |
| 1995 | -12.24% | A$18.27 | A$16.03 |
| 1994 | -40.24% | A$30.57 | A$18.27 |
Frequently Asked Questions: IMU
What sector is IMU in? ▼
IMU operates in the Healthcare sector, specifically in the Biotechnology industry. This sector includes pharmaceutical companies, biotechnology firms, medical device manufacturers, and healthcare providers.
How has IMU performed historically? ▼
Over 33 years of trading history, IMU has posted gains in 14 years (42% of the time). The best year was 2021 with a +300.0% return. Past performance does not guarantee future results.
How can I invest in IMU? ▼
You can invest in IMU through any brokerage account that offers access to the Australian Securities Exchange. Popular options include commission-free brokers like Fidelity, Charles Schwab, or Robinhood (US), or international brokers like Interactive Brokers. You can buy individual shares or invest through ETFs that hold IMU.
Last updated: 11/1/2026